Latest Breaking News On - Oz adler - Page 8 : vimarsana.com

SciSparc Announces IRB Approval to Conduct its Phase IIb Trial in Tourette Syndrome

SciSparc Announces IRB Approval to Conduct its Phase IIb Trial in Tourette Syndrome
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United statesTel avivMichaelh blochOz adlerTel aviv sourasky medical centerCompany or scisparcScisparc ltdHannover medical school inYale university school of medicineExchange commissionInstitutional review boardTourette syndromeYale global tic severity scaleChild study centerYale university schoolHannover medical school

SciSparc and Clearmind Medicine to Conduct a Study Evaluating Their Combination Treatment for Obesity and Metabolic Syndrome

The treatment combines SciSparc s Palmitoylethanolamide , the active pharmaceutical ingredient of its proprietary CannAmide™, and Clearmind’s MEAI, a novel proprietary psychedelic. | June 16, 2023

Israel generalTel avivJoseph tamJoseph yossi tamOz adlerMetabolism laboratoryCannabinoid researchMultidisciplinary centerCompany or scisparcHebrew university of jerusalemScisparc ltdExchange commissionClearmind medicine incScisparc palmitoylethanolamideClearmind medicineHebrew university

Scisparc : At-The-Market Issuance Sales Agreement - Form 6-K

At-The-Market Issuance Sales Agreement May 16, 2023 Aegis Capital Corp. 1345 Avenue of the Americas, 27th Floor New York, New. | May 17, 2023

New yorkUnited statesCity of new yorkAbba hillelRamat ganTel avivNorth koreaState of israelShachar hadarKost forer gabbay kasiererOz adlerRobert eideDarrinm ocasioOded harRobertj eideNeither the company

SciSparc Receives Final Approval to Commence its Phase IIb Clinical Trial for SCI-110 to treat Tourette Syndrome

SciSparc Receives Final Approval to Commence its Phase IIb Clinical Trial for SCI-110 to treat Tourette Syndrome
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesYale universityTel avivTanya gurevichOz adlerMichaelh blochHead of movement disorders unitGerman federal institute for drugsCompany or scisparcDepartment of psychiatryDrug administrationHannover medical schoolDepartment of neurologyScisparc ltdCompany phase iib clinical trialYale school of medicine

SciSparc (SPRC) Receives Final Approval to Commence its Phase IIb Clinical Trial for SCI-110 to treat Tourette Syndrome

SciSparc (SPRC) Receives Final Approval to Commence its Phase IIb Clinical Trial for SCI-110 to treat Tourette Syndrome
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Yale universityUnited statesTel avivOz adlerTanya gurevichMichaelh blochGerman federal institute for drugsHead of movement disorders unitCompany phase iib clinical trialYale child study centerDrug administrationDepartment of psychiatryHannover medical schoolCompany or scisparcDepartment of neurologyYale school of medicine